Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 2/20 | 0.64 |
| ▸ | MC4R | P32245 | 1/20 | 0.57 |
| ▸ | CXCR4 | P61073 | 4/20 | 0.57 |
| ▸ | CALCR | P30988 | 4/20 | 0.56 |
| ▸ | APLNR | P35414 | 3/20 | 0.56 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.54 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30233565 | 0.97 | C5AR1 (0.59) | C5AR1MC4RCXCR4CALCRAPLNR | |
| SCHEMBL30233448 | 0.95 | C5AR1 (0.60) | C5AR1MC4RCXCR4CALCRAPLNR | |
| SCHEMBL30233281 | 0.95 | C5AR1 (0.63) | C5AR1MC4RCXCR4CALCRAPLNR | |
| SCHEMBL30233422 | 0.95 | C5AR1 (0.58) | C5AR1CXCR4CALCRAPLNRNMUR2 | |
| SCHEMBL30233460 | 0.95 | CALCR (0.59) | C5AR1CALCROPRM1OPRD1 | |
| SCHEMBL30753755 | 0.94 | CALCR (0.62) | C5AR1MC4RCXCR4CALCROPRM1 | |
| SCHEMBL29843099 | 0.93 | C5AR1 (0.58) | C5AR1MC4RCXCR4CALCRAPLNR | |
| SCHEMBL30233411 | 0.93 | CALCR (0.63) | C5AR1CXCR4CALCROPRM1OPRD1 | |
| SCHEMBL30233814 | 0.93 | C5AR1 (0.63) | C5AR1MC4RCXCR4CALCR | |
| SCHEMBL30788366 | 0.92 | C5AR1 (0.58) | C5AR1MC4RCXCR4APLNROPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041740-A1 | SKIN PEEL COMPOSITIONS | GLO PHARMA INC (US) | 2024-02-08 | — | — | US | disclosed |